Fallbrook, CA, United States of America

Edward Roberts

USPTO Granted Patents = 17 

 

 

Average Co-Inventor Count = 6.2

ph-index = 4

Forward Citations = 59(Granted Patents)


Location History:

  • La Jolla, CA (US) (2013 - 2014)
  • Fallbrook, CA (US) (2010 - 2024)

Company Filing History:


Years Active: 2010-2024

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):

Title: Edward Roberts: Innovator in Kappa Opioid Receptor Antagonism

Introduction

Edward Roberts is a prominent inventor based in Fallbrook, CA (US), known for his significant contributions to the field of pharmacology. With a total of 17 patents to his name, he has made remarkable strides in the development of compounds that target the kappa-opioid receptor (KOR).

Latest Patents

Roberts' latest patents focus on kappa opioid receptor antagonists and the products and methods related to them. These patents provide compounds that antagonize the kappa-opioid receptor, along with products containing such compounds. The patents also detail methods for their use and synthesis. The compounds are characterized by a specific structure, which includes various isomers, racemates, hydrates, solvates, isotopes, or salts.

Career Highlights

Throughout his career, Edward Roberts has worked with esteemed organizations such as The Scripps Research Institute and Blackthorn Therapeutics, Inc. His work has significantly advanced the understanding and application of kappa-opioid receptor antagonists in therapeutic settings.

Collaborations

Roberts has collaborated with notable colleagues, including Miguel A Guerrero and Hugh Rosen, contributing to the innovative research in his field.

Conclusion

Edward Roberts stands out as a key figure in the development of kappa opioid receptor antagonists, with a robust portfolio of patents that reflect his dedication to advancing medical science. His work continues to influence the landscape of pharmacological research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…